Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Argus Health
Harvard Business School
Express Scripts
Farmers Insurance
Queensland Health
AstraZeneca
US Department of Justice
Colorcon

Generated: May 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,997,651

« Back to Dashboard

Summary for Patent: 4,997,651
Title: Pharmaceutical formulations
Abstract:The present invention relates to a new two-component pharmaceutical formulation of melphalan in which the two components comprise (a) freeze-dried mephalan hydrochloride and (b) a solvent-diluent comprising a citrate, propylene glycol and ethanol. Substantially pure melphalan, substantially pure melphalan hydrochloride and methods for preparing them are also described.
Inventor(s): Poole; Stephen W. (Dartford, GB2), Stanley; Timothy P. (Dartford, GB2), Divall; Geoffrey (Dartford, GB2), Packham; Terence W. (Dartford, GB2), Knight; Joseph (Dartford, GB2)
Assignee:
Application Number:07/273,227
Patent Claim Types:
see list of patent claims
Formulation; Process;

Drugs Protected by US Patent 4,997,651

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 4,997,651

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom8727157Nov 19, 1987

International Family Members for US Patent 4,997,651

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 83922 ➤ Try a Free Trial
Australia 2574888 ➤ Try a Free Trial
Australia 619781 ➤ Try a Free Trial
Canada 1341114 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Healthtrust
Julphar
Daiichi Sankyo
Dow
Colorcon
Argus Health
Farmers Insurance
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.